Jocelyn KaiserScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.Immunologist Rick Bright, who was removed as director of the federal Biomedical Advanced Research and Development Authority (BARDA) in April 2020 by the Trump administration after he pushed back against investing in the malaria drug hydroxychloroquine to treat COVID-19, will lead a new private effort to improve defenses against pandemics, both present and future.
The Rockefeller Foundation today announced Bright will be its senior vice president for pandemic prevention and response, leading efforts “to avert future pandemics by identifying and responding to the earliest alerts of a disease outbreak and stopping it in the first 100 days.”The foundation.